Editorial
Management of invasive and non-invasive breast cancer in the United States and China
Chinese Clinical Oncology
2016;
5
(3)
:30
.
(01 June 2016)
Review Article
The United States’ national accreditation program for breast centers: a model for excellence in breast disease evaluation and management
Chinese Clinical Oncology
2016;
5
(3)
:31
.
(01 June 2016)
Contemporary management of ductal carcinoma in situ and lobular carcinoma in situ
Chinese Clinical Oncology
2016;
5
(3)
:32
.
(01 June 2016)
Ultrasound image-guided core biopsy of the breast
Chinese Clinical Oncology
2016;
5
(3)
:33
.
(01 June 2016)
Advances in the surgical treatment of breast cancer
Chinese Clinical Oncology
2016;
5
(3)
:34
.
(01 June 2016)
Appropriate margin for lumpectomy excision of invasive breast cancer
Chinese Clinical Oncology
2016;
5
(3)
:35
.
(01 June 2016)
The staging value of sentinel lymph node biopsy for breast cancer: translating pathologic findings to clinical practice
Chinese Clinical Oncology
2016;
5
(3)
:36
.
(01 June 2016)
The timing of breast and axillary surgery after neoadjuvant chemotherapy for breast cancer
Chinese Clinical Oncology
2016;
5
(3)
:37
.
(01 June 2016)
Indications for adjuvant radiation therapy in breast cancer: a review of the evidence and recommendations for clinical practice
Chinese Clinical Oncology
2016;
5
(3)
:38
.
(01 June 2016)
Alternatives to whole breast irradiation in early breast cancer
Chinese Clinical Oncology
2016;
5
(3)
:39
.
(01 June 2016)
Endocrine therapy as adjuvant or neoadjuvant therapy for breast cancer: selecting the best agents, the timing and duration of treatment
Chinese Clinical Oncology
2016;
5
(3)
:40
.
(01 June 2016)
HER2-positive breast cancer, how far away from the cure?—on the current situation of anti-HER2 therapy in breast cancer treatment and survival of patients
Chinese Clinical Oncology
2016;
5
(3)
:41
.
(01 June 2016)
Chemotherapy principles of managing stage IV breast cancer in the United States
Chinese Clinical Oncology
2016;
5
(3)
:42
.
(01 June 2016)
Training of breast surgical oncologists
Chinese Clinical Oncology
2016;
5
(3)
:43
.
(01 June 2016)
The role of Advanced Practice Providers in interdisciplinary oncology care in the United States
Chinese Clinical Oncology
2016;
5
(3)
:44
.
(01 June 2016)
Organizing a breast cancer database: data management
Chinese Clinical Oncology
2016;
5
(3)
:45
.
(01 June 2016)
The way to precision medicine of our team
Chinese Clinical Oncology
2016;
5
(3)
:46
.
(01 June 2016)
Genetic testing for hereditary breast cancer in Asia—moving forward
Chinese Clinical Oncology
2016;
5
(3)
:47
.
(01 June 2016)
Disclosure:
The focused issue “Multidisciplinary Management of Breast Cancer” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Charles M. Balch, Ning Liao and Kelly K. Hunt served as the unpaid Guest Editors for the focused issue.
